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Child pneumonia at a time of epidemiological transition 
Some important changes have occurred in global child 
health in the past decade. Socioeconomic development, 
action to address the broad social determinants of 
health,1 and the development and implementation of 
eﬀ ective child health interventions2 have resulted in 
a steady and substantial fall in global child mortality.3 
Mortality due to pneumonia, the leading cause of child 
death in the past decade, has fallen the most steeply. 
These changes have also resulted in a changing pattern 
of pneumonia incidence, cause, and risk-factor eﬀ ects. 
Therefore, particularly at this time, reliable information 
about the epidemiology of pneumonia in low-income 
and middle-income countries should be collected, 
disseminated, and used to inform child health policy 
and priority setting. Since vital statistics and other 
routine health information are not widely available in 
the countries and regions with the highest child disease 
burden, to a large extent researchers are reliant on well 
designed and implemented population-based research 
in these settings to provide this essential information.
The excellent birth cohort study reported in The Lancet 
Global Health by Heather Zar and colleagues,4 done in a 
periurban area outside Cape Town in South Africa, is a 
good example of a study that has provided important 
information about child pneumonia at a time of change. 
It provides the ﬁ rst incidence estimates of pneumonia 
and severe pneumonia in a low-to-middle-income 
country (LMIC) population, with high coverage of both 
(13 valent) pneumococcal and Haemophilus inﬂ uenzae 
type b conjugate vaccines, and with roughly a ﬁ fth 
of the cohort being HIV-exposed but uninfected. On 
a background of falling pneumonia incidence over 
the past decade,5 these estimates show that, despite 
an eﬀ ective vaccination programme addressing the 
two major causes of pneumonia death, pneumonia 
continues to be a major burden on health services in 
this South African population. Worldwide, it remains a 
major cause of care-seeking for child illness, attendance 
at clinics, admission to hospital, and prescription of 
antibiotics. This study suggests that the modelled 
annual incidence estimates for South Africa in 
2010, using a risk factor model that included HIV, of 
0·22 episodes in children aged younger than 5 years, 
are broadly consistent with estimates reported in 
Theodoratou and colleagues’ study.6 This ﬁ nding would 
equate to 1·12 million new cases in South Africa each 
year in this age group.
Although pneumococci and H inﬂ uenzae type b are 
major causes of child death from pneumonia, they 
account for a small proportion of overall pneumonia 
episodes7 and hence, as Zar and colleagues4 point 
out, continuing investment in social determinants of 
pneumonia and scaling up of the coverage of other 
known eﬀ ective interventions2 is needed. This investment 
should also give priority to cross-sectoral approaches, 
with action on determinants such as maternal education, 
with appropriate attention given to address the problems 
of minority and disadvantaged populations. Investment 
in innovation to tackle other important causes of the 
remaining pneumonia burden, such as respiratory 
syncytial virus and inﬂ uenza,8,9 is also needed.
The study also points out some other important 
aspects of the pneumonia burden. Increasingly, the 
major pneumonia burden is in the ﬁ rst 2 years of 
life (rather than the international focus on children 
aged younger than 5 years).10 Additionally, severe 
pneumonia accounting for most pneumonia deaths 
occurs in the ﬁ rst 6 months of life (in this study 26 of 
32 of severe episodes had occurred by age 2 months), 
which might need increasing attention in programme-
priority setting. As part of an epidemiological transition 
accompanying the trends reported here, wheeze is 
an increasingly important presentation in children 
presenting with cough and diﬃ  culty breathing 
(reported in 65% of cases in this study), which merits 
further research to reduce antibiotic over-treatment and 
promote correct treatment of wheeze in these children. 
The male to female incidence ratio of 2:1 is substantially 
larger than the established (slight) increased pneumonia 
risk due to so-called biological frailty in boys and points 
to the need to explore possible gender discrimination 
in care-seeking. Although the study reports an active 
surveillance system, this system is in fact an active case 
ascertainment within an essentially passive surveillance 
system, which could have led to missed cases (when care 
was not sought) and diﬀ erential care-seeking by gender. 
Alarming levels of diﬀ erential hospital admissions 
of children with pneumonia by gender have been 
reported in some LMICs.11 If the full eﬀ ect of eﬀ ective 
interventions against childhood pneumonia is to be 
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realised, then gender discrimination in some countries 
needs to be recognised as a major source of inequity in 
child health. Reporting of child health data by sex, as 
in this study, needs to be seen as an essential element 
of good practice in the reporting of child health data 
so that attention can be drawn to sex discrimination, 
where it exists.
The study reports the occurrence of several episodes 
of pneumonia in a high proportion of children (with 
about 40 of 141 episodes representing repeat episodes; 
22 children had two episodes and nine children had 
three episodes out of 141 pneumonia episodes). More 
insight could have gained if more information was 
known about these children. Did they have a greater 
prevalence of known risk factors, such as malnutrition, 
low birthweight, lack of exclusive breastfeeding, or HIV 
exposure, than expected in this population? Targeted 
monitoring of these children over the subsequent 
few months might be justiﬁ able. Whether all or most 
episodes were acute in nature would be interesting to 
know, as well as whether a substantial proportion were 
due to chronic infections (with some of the apparent 
repeated episodes truly representing episodes with a 
more chronic course).
The highly seasonal pattern is consistent with a largely 
viral cause and has implications for health service and 
logistical planning to ensure availability of essential 
health commodities throughout the year. The separate 
identiﬁ cation of fast breathing in the ﬁ rst day of life 
as being due to causes other than pneumonia, such as 
congenital causes, is important, as well as recognition 
that interventions other than simply antibiotics could 
be used.
High-quality birth cohort studies are expensive and 
challenging to do and need a well supported research 
group with a high level of technical capability and 
expertise. This study is a good example of such a study 
yielding reliable data that can inform child heath 
planning, raise important child health policy issues that 
merit further investigation, and identify important 
issues for future research.
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